Respiratory Inhalers Market By Type (Dry Powder Inhalers, Metered Dose Inhalers, Nebulizers), By Application (Asthma, Chronic Obstructive Pulmonary Disorder, Pulmonary Arterial Hypertension, Cystic Fibrosis), By Technology (Digital, Manual) - Growth, Future Prospects & Competitive Analysis, 2017 – 2025
Respiratory inhalers are used to administer an extensive range of medications such as beta-agonists, anticholinergic, corticosteroids and certain antibiotics. Respiratory inhalers are used to provide relief of symptoms in various respiratory conditions such as asthma, chronic obstructive pulmonary disorder (COPD), pulmonary arterial hypertension, bronchitis and cystic fibrosis. In such respiratory conditions both mild and severe symptoms occur such as coughing, shortness of breath, chest congestion, respiratory discomfort and even death in extreme cases. Thus it becomes important to relieve the symptoms immediately which is accomplished by the use of inhalers.
Drug administration by inhalers is most widely prescribed as it requires lesser doses to give quick relief thus reducing the risk of side effects unlike oral medications. The rise in prevalence of the aforementioned respiratory conditions and the continuous rise in environmental pollution has led to the rise in growth of respiratory inhaler market in the current and forecast period, 2017-2025.
The current study report on respiratory inhalers provides an in depth insight on the market trends and dynamics. The report includes market estimations and forecast data for the period 2017-2025. The market has been analyzed and studied into various segments which are as follows:
- Type
- Dry powder Inhalers
- Metered Dose Inhalers
- Pressurized
- Breath-actuated
- Non-pressurized
- Nebulizers
- Jet nebulizer
- Mesh nebulizer
- Ultrasonic nebulizer
- Application
- Asthma
- Chronic Obstructive Pulmonary Disorder
- Pulmonary Arterial Hypertension
- Cystic Fibrosis
- Others
- Technology
- Digital
- Manual
The respiratory inhalers market have also been studied across geographies. For the purpose of this study the respiratory inhalers market is segmented based on geographies as follows:
- North America
- USA
- Canada
- Europe
- U.K
- Germany
- Rest of Europe
- Asia Pacific
- Japan
- China
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- GCC
- Rest of Middle East and Africa
Market evaluation and forecast analysis for the above mentioned segments for the duration 2015-2025 has been incorporated in this report. The values are have been represented in terms of US$ Mn. Furthermore, the respective growth rates for each of the mentioned segments has also been inculcated with 2016 as the base year.
This report also comprehends qualitative insights with respect to market restraints, opportunities and drivers. These insights provides an overview of the entire market and would assist emerging players to strategize their product growth within this market. A competitive landscape depicting market position of the industrial players has also been incorporated win this report. Company profiles of each of the industrial leaders with respect to financial performance, product portfolio, current market trends and general information has been incorporated. The profiles of major industrial leaders incorporated are Boehringer Ingelheim GmbH, Astra Zeneca, PARI Medical Holding, Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., Cipla Inc., GlaxoSmithKline plc, Beximco Pharmaceuticals Ltd., Sandoz, Baxter International, OMRON Healthcare Europe B.V, Propeller Health, Adherium and others.
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted
Chapter 2. Executive Summary
2.1. Global Respiratory Inhalers Market Portraiture
2.2. Global Respiratory Inhalers Market, by Type, 2016 (US$ Mn)
2.3. Global Respiratory Inhalers Market, by Application, 2016 (US$ Mn)
2.4. Global Respiratory Inhalers Market, by Technology, 2016 (US$ Mn)
2.5. Global Respiratory Inhalers Market Share, by Geography, 2016 vs. 2025 (Value %)
Chapter 3. Global Respiratory Inhalers Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Respiratory Inhalers: Future Trends
3.3. Drivers
3.4. Challenges
3.5. Opportunities
3.6. Attractive Investment Proposition, by Geography, 2016
3.7. Major Agreements, Partnerships and Collaborations
3.8. Competitive Landscape, by Key Players, 2016
Chapter 4. Global Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
4.1. Overview
4.1.1. Attractive Investment Proposition: Global Respiratory Inhalers Market, by Type, 2016
4.2. Dry powder Inhalers
4.3. Metered Dose Inhalers
4.3.1. Pressurized
4.3.2. Breath-actuated
4.3.3. Non-pressurized
4.4. Nebulizers
4.4.1. Jet nebulizer
4.4.2. Mesh nebulizer
4.4.3. Ultrasonic nebulizer
Chapter 5. Global Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
5.1. Overview
5.1.1. Attractive Investment Proposition: Global Respiratory Inhalers Market, by Application, 2016
5.2. Asthma
5.3. Chronic Obstructive Pulmonary Disorder
5.4. Pulmonary Arterial Hypertension
5.5. Cystic Fibrosis
5.6. Others
Chapter 6. Global Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
6.1. Overview
6.1.1. Attractive Investment Proposition: Global Respiratory Inhalers Market, by Technology, 2016
6.2. Digital
6.3. Manual
Chapter 7. Global Respiratory Inhalers Market, by Geography, 2015 – 2025 (US$ Mn)
7.1. Overview
7.2. North America Respiratory Inhalers Market Analysis, 2015 – 2025
7.2.1. North America Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.2.2. North America Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.2.3. North America Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.2.4. North America Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe Respiratory Inhalers Market Analysis, 2015 – 2025
7.3.1. Europe Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.3.2. Europe Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.3.3. Europe Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.3.4. Europe Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific Respiratory Inhalers Market Analysis, 2015 – 2025
7.4.1. Asia Pacific Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.4.2. Asia Pacific Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.4.3. Asia Pacific Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.4.4. Asia Pacific Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America Respiratory Inhalers Market Analysis, 2015 – 2025
7.5.1. Latin America Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.5.2. Latin America Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.5.3. Latin America Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.5.4. Latin America Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.5.4.1. Mexico
7.5.4.2. Brazil
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) Respiratory Inhalers Market Analysis, 2015 – 2025
7.6.1. MEA Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
7.6.2. MEA Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
7.6.3. MEA Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
7.6.4. MEA Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA
Chapter 8. Company Profiles
8.1. Adherium
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Astra Zeneca plc
8.3. Beximco Pharmaceuticals Ltd.
8.4. Boehringer Ingelheim GmbH
8.5. Cipla Inc.
8.6. GlaxoSmithKline plc
8.7. Merck & Co., Inc.
8.8. OMRON Healthcare Europe B.V
8.9. PARI Medical Holding
8.10. Propeller Health
8.11. Sandoz, Baxter International
8.12. Teva Pharmaceutical Industries Ltd.
TABLE 1 Global Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 2 Global Respiratory Inhalers Market, by Application, 2016 (US$ Mn)
TABLE 3 Global Respiratory Inhalers Market, by Technology, 2016 (US$ Mn)
TABLE 4 Global Respiratory Inhalers Market Share, by Geography, 2015 – 2025 (Value %)
TABLE 5 North America Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 6 North America Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 7 North America Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 8 North America Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 9 Europe Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 10 Europe Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 11 Europe Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 12 Europe Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 13 Asia Pacific Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 14 Asia Pacific Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 15 Asia Pacific Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 16 Asia Pacific Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 17 Latin America Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 18 Latin America Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 19 Latin America Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 20 Latin America Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 21 Middle East And Africa Respiratory Inhalers Market, by Type, 2015 – 2025 (US$ Mn)
TABLE 22 Middle East And Africa Respiratory Inhalers Market, by Application, 2015 – 2025 (US$ Mn)
TABLE 23 Middle East And Africa Respiratory Inhalers Market, by Technology, 2015 – 2025 (US$ Mn)
TABLE 24 Middle East And Africa Respiratory Inhalers Market, by Country, 2015 – 2025 (US$ Mn)
TABLE 25 Adherium: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Astra Zeneca: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Beximco Pharmaceuticals Ltd. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 Boehringer Ingelheim GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Cipla Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 30 GlaxoSmithKline plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 31 Merck & Co., Inc. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 32 OMRON Healthcare Europe B.V: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 33 PARI Medical Holding: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 34 Propeller Health: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 35 Sandoz, Baxter International: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 36 Teva Pharmaceutical Industries Ltd. : Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
FIG. 1 Respiratory Inhalers: Market Segmentation
FIG. 2 Attractive Investment Proposition, by Geography, 2016
FIG. 3 Market Competition Landscape, by Key Players, 2016
FIG. 4 Global Dry Powder Inhalers Market In Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 5 Global Pressurized Metered Dose Inhalers Market In Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 6 Global Breath-actuated Metered Dose Inhalers Market In Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 7 Global Non-Pressurized Metered Dose Inhalers Market in Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 8 Global Jet Nebulizer Market in Respiratory Inhalers, 2015 – 2025 (US$ Mn)
FIG. 9 Global Mesh Nebulizer Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 10 Global Ultrasonic Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 11 Global Asthma Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 12 Global Chronic Obstructive Pulmonary Disorder Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 13 Global Pulmonary Arterial Hypertension Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 14 Global Cystic Fibrosis Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 15 Global Other Applications Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 16 Global Digital Inhalers Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 17 Global Manual Inhalers Market in Respiratory Inhalers , 2015 – 2025 (US$ Mn)
FIG. 18 U.S. Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 19 Canada Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 20 U.K. Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 21 Germany Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 22 Rest Of Europe Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 23 Japan Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 24 China Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 25 Rest Of Asia Pacific Respiratory Inhalers Market, 2015 – 2025 (US$ Mn)
FIG. 26 Mexico Digital Therapeutic Market 2015-2025 (US$ Mn)
FIG. 27 Brazil Respiratory Inhalers Market 2015-2025 (US$ Mn)
FIG. 28 Rest of Latin America Respiratory Inhalers Market 2015-2025 (US$ Mn)
FIG. 29 GCC Respiratory Inhalers Market 2015-2025 (US$ Mn)
FIG. 30 Rest of MEA Respiratory Inhalers Market 2015-2025 (US$ Mn)
Choose License
Contact Information
: sales@briskinsights.com
: +448081890034 (UK)